Precigen Inc
PGENNASDAQStock · Data from SEC EDGAR 13F · Held by 1 of 87 tracked investors
Precigen Inc at a glance
An overview of the financial statements, in plain language. Switch to the advanced view for charts.
- Valuation15
- Growth36
- Profitability50
- Quality20
- Debt15
- Stability30
- ✓The analysts' average target is 122% above the price.
- !The company is loss-making: net profit is negative.
- !Free cash flow is negative and the company has debt.
- !Revenue fell 28.9% a year over 3 years.
- !In some year revenue fell sharply.
The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.
Is the stock expensive?
ExpensiveThe company has no earnings, so the P/E cannot be calculated.
- P/E
- –
- P/S
- 25.7×
- EV/EBITDA
- -62.9×
Is the company growing?
ShrinkingRevenue over 3 years grew -28.9% a year. Last year 6,322.7%.
Does it make money?
Loss-makingChart PGEN
Insider purchases
last 90 days, SEC Form 4Which investors hold this stock
1SM Samantha McLemore Patient Capital Management | 3.56% |
Frequently asked questions
How much is Precigen Inc (PGEN) stock?
Precigen Inc shares trade at $6.15, +1.82% over the last trading day. The price is delayed.
What is the market cap of Precigen Inc?
The market cap of Precigen Inc is about $2.2B.
Which big investors hold Precigen Inc?
According to the latest 13F filings, 1 of 87 tracked investors hold Precigen Inc, for example Samantha McLemore.
When will Precigen Inc report its next results?
The next earnings report of Precigen Inc is expected on 12 Nov 2026.
Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.